Normal view MARC view ISBD view

A comparative study of catalytic partial oxidation of methane over CeO2 supported metallic catalysts. [electronic resource]

By:

Ahn, Kiyong

Contributor(s):

Producer: 20120105Description: 6414-9 p. digitalISSN:

1533-4880

Online resources:

Available from publisher's website

In: Journal of nanoscience and nanotechnology vol. 11

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

2121 Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product.
by Kallestrup, Else B
2122 Prevalence of interstitial cystitis in vulvodynia patients detected by bladder potassium sensitivity.
by Kahn, Bruce S
2123 Down-regulation of annexin A1 in the urothelium decreases cell survival after bacterial toxin exposure.
by Monastyrskaya, Katia
2124 Suplatast tosilate in patients with interstitial cystitis: Efficacy and treatment possibilities, with suggestions for future assessments.
by Ueda, Tomohiro
2125 Follow-up of the remaining bladder after supravesical urinary diversion.
by Granados, E A
2126 Estrogen and neuroinflammation.
by Bjorling, D E
2127 Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis.
by Green, M
2128 Highlights in basic autonomic neuroscience: contribution of the urothelium to sensory mechanisms in the urinary bladder.
by de Groat, William C
2129 A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
by Cervigni, Mauro
2130 Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
by Cui, Xiangrong
2131 There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally.
by Stanford, Edward
2132 Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women.
by Barry, Michael J
2133 Hyaluronan treatment of interstitial cystitis/painful bladder syndrome.
by Riedl, Claus R
2134 Migraine comorbidity constellations.
by Tietjen, Gretchen E
2135 Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis.
by Altuntas, Cengiz Z
2136 [A new experimental model for inducing interstitial cystitis by oxidative stress using bladder instillation of a nitric oxide donor gel].
by Palma, T F
2137 Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis.
by Evans, R J
2138 Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets.
by Arai, Takayuki
2139 Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT.
by Crane, Alice
2140 Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis.
by u Zhang, Chen-O